Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pancreatic cancer: Advances and challenges
Christopher J. Halbrook, Costas A. Lyssiotis, Marina Pasca di Magliano, et al.
Cell (2023) Vol. 186, Iss. 8, pp. 1729-1754
Open Access | Times Cited: 529

Showing 1-25 of 529 citing articles:

IL-1β+ macrophages fuel pathogenic inflammation in pancreatic cancer
Nicoletta Caronni, Federica La Terza, Francesco Maria Vittoria, et al.
Nature (2023) Vol. 623, Iss. 7986, pp. 415-422
Closed Access | Times Cited: 123
Positive feedback regulation between glycolysis and histone lactylation drives oncogenesis in pancreatic ductal adenocarcinoma
Fei Li, Wenzhe Si, Li Xia, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 46
Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma
Abdelrahman Yousef, Mahmoud Yousef, Saikat Chowdhury, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 38
Mapping functional to morphological variation reveals the basis of regional extracellular matrix subversion and nerve invasion in pancreatic cancer
Pierluigi Di Chiaro, Lucia Nacci, Fabiana Arco, et al.
Cancer Cell (2024) Vol. 42, Iss. 4, pp. 662-681.e10
Open Access | Times Cited: 23
Liquid biopsy in cancer current: status, challenges and future prospects
Liwei Ma, Huiling Guo, Yunxiang Zhao, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 23
Development of pharmacological immunoregulatory anti-cancer therapeutics: current mechanistic studies and clinical opportunities
Nanhao Yin, Xintong Li, Xuanwei Zhang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 19
Schwann cells in pancreatic cancer: Unraveling their multifaceted roles in tumorigenesis and neural interactions
Zhiwei Cai, Hong-Fei Yao, Jiahao Chen, et al.
Cancer Letters (2024) Vol. 587, pp. 216689-216689
Closed Access | Times Cited: 17
From Machine Learning to Patient Outcomes: A Comprehensive Review of AI in Pancreatic Cancer
Satvik Tripathi, Azadeh Tabari, Arian Mansur, et al.
Diagnostics (2024) Vol. 14, Iss. 2, pp. 174-174
Open Access | Times Cited: 16
Molecular mechanisms of pancreatic cancer liver metastasis: the role of PAK2
Hao Yang, Zhong‐Yi Li, Shiqi Zhu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 16
Lactate and lactylation in cancer
Jie Chen, Ziyue Huang, Ya Chen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 6
AGER-dependent macropinocytosis drives resistance to KRAS-G12D–targeted therapy in advanced pancreatic cancer
Changfeng Li, Yuanda Liu, Chang Liu, et al.
Science Translational Medicine (2025) Vol. 17, Iss. 783
Closed Access | Times Cited: 2
Targeting pancreatic cancer metabolic dependencies through glutamine antagonism
Joel Encarnación-Rosado, Albert S.W. Sohn, Douglas E. Biancur, et al.
Nature Cancer (2023) Vol. 5, Iss. 1, pp. 85-99
Open Access | Times Cited: 38
A Small Molecule with Big Impact: MRTX1133 Targets the KRASG12D Mutation in Pancreatic Cancer
Daoyan Wei, Liang Wang, Xiangsheng Zuo, et al.
Clinical Cancer Research (2023) Vol. 30, Iss. 4, pp. 655-662
Open Access | Times Cited: 35
Activation of the PI3K/AKT signaling pathway by ARNTL2 enhances cellular glycolysis and sensitizes pancreatic adenocarcinoma to erlotinib
Weiyu Ge, Y Wang, Ming Quan, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 14
Early Diagnosis and Prognosis Prediction of Pancreatic Cancer Using Engineered Hybrid Core‐Shells in Laser Desorption/Ionization Mass Spectrometry
Juxiang Zhang, Fei Teng, Beiyuan Hu, et al.
Advanced Materials (2024) Vol. 36, Iss. 18
Closed Access | Times Cited: 13
The Roles and Interactions of Porphyromonas gingivalis and Fusobacterium nucleatum in Oral and Gastrointestinal Carcinogenesis: A Narrative Review
Bing Wang, Juan Deng, Valentina Donati, et al.
Pathogens (2024) Vol. 13, Iss. 1, pp. 93-93
Open Access | Times Cited: 13
Oncogenic KRAS-Dependent Stromal Interleukin-33 Directs the Pancreatic Microenvironment to Promote Tumor Growth
Katelyn L. Donahue, Hannah R. Watkoske, Padma Kadiyala, et al.
Cancer Discovery (2024) Vol. 14, Iss. 10, pp. 1964-1989
Open Access | Times Cited: 11
ALYREF-JunD-SLC7A5 axis promotes pancreatic ductal adenocarcinoma progression through epitranscriptome-metabolism reprogramming and immune evasion
Qingbo Meng, Yuting Xie, Kang Sun, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 9
Electrochemiluminescence biosensor for specific detection of pancreatic ductal carcinoma through dual targeting of MUC1 and miRNA-196a
Yuxuan Chen, Zhuoxin Ye, Mo Ma, et al.
Biosensors and Bioelectronics (2024) Vol. 254, pp. 116241-116241
Closed Access | Times Cited: 9
The MUC1–HIF-1α signaling axis regulates pancreatic cancer pathogenesis through polyamine metabolism remodeling
Divya Murthy, Kuldeep S. Attri, Voddu Suresh, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 14
Open Access | Times Cited: 9
Intratumoral CD38+CD19+B cells associate with poor clinical outcomes and immunosuppression in patients with pancreatic ductal adenocarcinoma
Heng Zhu, Jin Xu, Wei Wang, et al.
EBioMedicine (2024) Vol. 103, pp. 105098-105098
Open Access | Times Cited: 9
NIR Fluorescent/Photoacoustic Bimodal Imaging of Ferroptosis in Pancreatic Cancer Using Biothiols-Activable Probes
Lingyun Li, Zhipengjun Zhang, Lei Zhou, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 18, pp. 7248-7256
Closed Access | Times Cited: 9
An emerging strategy: probiotics enhance the effectiveness of tumor immunotherapy via mediating the gut microbiome
Shuaiming Jiang, Wenyao Ma, Chenchen Ma, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 9
Recent Trends in Curcumin-Containing Inorganic-Based Nanoparticles Intended for In Vivo Cancer Therapy
Douglas Dourado, Júlio Abreu Miranda, Matheus de Oliveira, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 177-177
Open Access | Times Cited: 8
Intercellular crosstalk between cancer cells and cancer-associated fibroblasts via exosomes in gastrointestinal tumors
Longyang Cao, Hong Ouyang
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top